253 related articles for article (PubMed ID: 35929879)
1. Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021).
Mao Z; Li X; Wang P; Yan H
Expert Opin Ther Pat; 2022 Sep; 32(9):939-952. PubMed ID: 35929879
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from
Sheervalilou R; Shirvaliloo M; Sargazi S; Ghaznavi H
Expert Opin Drug Deliv; 2021 Jul; 18(7):949-977. PubMed ID: 33567919
[No Abstract] [Full Text] [Related]
3. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.
Aboushoushah S; Alshammari W; Darwesh R; Elbaily N
Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288
[TBL] [Abstract][Full Text] [Related]
4. Hepatotoxic and Neurotoxic Potential of Iron Oxide Nanoparticles in Wistar Rats: a Biochemical and Ultrastructural Study.
Mabrouk M; Ibrahim Fouad G; El-Sayed SAM; Rizk MZ; Beherei HH
Biol Trace Elem Res; 2022 Aug; 200(8):3638-3665. PubMed ID: 34704196
[TBL] [Abstract][Full Text] [Related]
5. Iron oxide nanoparticle targeting mechanism and its application in tumor magnetic resonance imaging and therapy.
Wu L; Wang C; Li Y
Nanomedicine (Lond); 2022 Sep; 17(21):1567-1583. PubMed ID: 36458585
[TBL] [Abstract][Full Text] [Related]
6. Chemical transformation and cytotoxicity of iron oxide nanoparticles (IONPs) accumulated in mitochondria.
Ruan L; Li H; Zhang J; Zhou M; Huang H; Dong J; Li J; Zhao F; Wu Z; Chen J; Chai Z; Hu Y
Talanta; 2023 Jan; 251():123770. PubMed ID: 35961081
[TBL] [Abstract][Full Text] [Related]
7. Surface engineering of magnetic iron oxide nanoparticles by polymer grafting: synthesis progress and biomedical applications.
Hou Z; Liu Y; Xu J; Zhu J
Nanoscale; 2020 Jul; 12(28):14957-14975. PubMed ID: 32648868
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Iron Oxide Nanoparticle (IONP) Synthesis to Applications: Present and Future.
Ajinkya N; Yu X; Kaithal P; Luo H; Somani P; Ramakrishna S
Materials (Basel); 2020 Oct; 13(20):. PubMed ID: 33080937
[TBL] [Abstract][Full Text] [Related]
9. Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications.
Etemadi H; Buchanan JK; Kandile NG; Plieger PG
ACS Biomater Sci Eng; 2021 Dec; 7(12):5432-5450. PubMed ID: 34786932
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant Iron Oxide Nanoparticles: Their Biocompatibility and Bioactive Properties.
Lee J; Lee JH; Lee SY; Park SA; Kim JH; Hwang D; Kim KA; Kim HS
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958885
[TBL] [Abstract][Full Text] [Related]
11. The effect of neutral-surface iron oxide nanoparticles on cellular uptake and signaling pathways.
Kim E; Kim JM; Kim L; Choi SJ; Park IS; Han JY; Chu YC; Choi ES; Na K; Hong SS
Int J Nanomedicine; 2016; 11():4595-4607. PubMed ID: 27695320
[TBL] [Abstract][Full Text] [Related]
12. Facile Synthesis and Characterization of L-Aspartic Acid Coated Iron Oxide Magnetic Nanoparticles (IONPs) For Biomedical Applications.
Salehiabar M; Nosrati H; Davaran S; Danafar H; Manjili HK
Drug Res (Stuttg); 2018 May; 68(5):280-285. PubMed ID: 29036735
[TBL] [Abstract][Full Text] [Related]
13. Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008 - present).
El-Hammadi MM; Arias JL
Expert Opin Ther Pat; 2015 Jun; 25(6):691-709. PubMed ID: 25800416
[TBL] [Abstract][Full Text] [Related]
14. Imaging the distribution of iron oxide nanoparticles in hypothermic perfused tissues.
Ring HL; Gao Z; Sharma A; Han Z; Lee C; Brockbank KGM; Greene ED; Helke KL; Chen Z; Campbell LH; Weegman B; Davis M; Taylor M; Giwa S; Fahy GM; Wowk B; Pagotan R; Bischof JC; Garwood M
Magn Reson Med; 2020 May; 83(5):1750-1759. PubMed ID: 31815324
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.
Pillarisetti S; Uthaman S; Huh KM; Koh YS; Lee S; Park IK
Tissue Eng Regen Med; 2019 Oct; 16(5):451-465. PubMed ID: 31624701
[TBL] [Abstract][Full Text] [Related]
16. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
[TBL] [Abstract][Full Text] [Related]
17. Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.
Kucharczyk K; Rybka JD; Hilgendorff M; Krupinski M; Slachcinski M; Mackiewicz A; Giersig M; Dams-Kozlowska H
PLoS One; 2019; 14(7):e0219790. PubMed ID: 31306458
[TBL] [Abstract][Full Text] [Related]
18. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications.
Frtús A; Smolková B; Uzhytchak M; Lunova M; Jirsa M; Kubinová Š; Dejneka A; Lunov O
J Control Release; 2020 Dec; 328():59-77. PubMed ID: 32860925
[TBL] [Abstract][Full Text] [Related]
19. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
Dan M; Bae Y; Pittman TA; Yokel RA
Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
[TBL] [Abstract][Full Text] [Related]
20. Limitations and caveats of magnetic cell labeling using transfection agent complexed iron oxide nanoparticles.
Soenen SJ; De Smedt SC; Braeckmans K
Contrast Media Mol Imaging; 2012; 7(2):140-52. PubMed ID: 22434626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
